Boston Scientific CFO Dan Brennan to retire; Jon Monson named successor effective June 30, 2025

BOSTON SCIENTIFIC CORP

Dan Brennan retires as EVP & CFO effective June 29, 2025; will remain senior advisor to October 3, 2025.
Jon Monson promoted to EVP & CFO effective June 30, 2025; previously SVP, Investor Relations and global controller.
Monson receives base salary of $700,000, bonus target of 80%, and $1.75M equity award vesting over 4 years.
Monson has been with Boston Scientific for 25+ years; played key roles in finance during pandemic and strategic investments.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jonathan Monson

Executive Vice President and Chief Financial Officer

BSX · BOSTON SCIENTIFIC CORP

Effective: 2025-06-30
Filed: April 23, 2025, 7:59 PM ET

Jonathan Monson, who currently serves as Senior Vice President, Investor Relations, has been promoted to Executive Vice President and Chief Financial Officer of the Company effective as of June 30, 2025

Departed

Daniel J. Brennan

Executive Vice President and Chief Financial Officer

BSX · BOSTON SCIENTIFIC CORP

Effective: 2025-06-29
Successor: Jonathan Monson
Filed: April 23, 2025, 7:59 PM ET

On April 23, 2025, Boston Scientific Corporation (the “Company”) announced that Daniel J. Brennan has decided to retire from his role as Executive Vice President and Chief Financial Officer of the Company effective as of June 29, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jonathan Monson was appointed as Executive Vice President and Chief Financial Officer at BOSTON SCIENTIFIC CORP.

Action: promoted
Role: Executive Vice President and Chief Financial Officer

Exact text from the filing

Jonathan Monson, who currently serves as Senior Vice President, Investor Relations, has been promoted to Executive Vice President and Chief Financial Officer of the Company effective as of June 30, 2025

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel J. Brennan departed as Executive Vice President and Chief Financial Officer at BOSTON SCIENTIFIC CORP.

Action: retire
Role: Executive Vice President and Chief Financial Officer

Exact text from the filing

On April 23, 2025, Boston Scientific Corporation (the “Company”) announced that Daniel J. Brennan has decided to retire from his role as Executive Vice President and Chief Financial Officer of the Company effective as of June 29, 2025

View on SEC.gov

BOSTON SCIENTIFIC CORP filing history →

Source: SEC EDGAR

accession 0000885725-25-000024

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.